Stocks and Investing
Stocks and Investing
Thu, August 30, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 29, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 28, 2018
Eliana Merle Initiated (ANAB) at Buy and Held Target at $124 on, Aug 28th, 2018
Eliana Merle of Cantor Fitzgerald, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $124 on, Aug 28th, 2018.
Eliana has made no other calls on ANAB in the last 4 months.
There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with Eliana's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Eliana
- Konstantinos Aprilakis of "JMP Securities" Maintained at Buy with Decreased Target to $153 on, Wednesday, August 15th, 2018
- Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $104 on, Thursday, July 19th, 2018